Temozolomide in Aggressive Pituitary Neuroendocrine Tumors: A Latin American Multicenter Retrospective Cohort (TMZ-LATAM)
Clinical trial NCT07695844 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07695844
- Sponsor
- University of Sao Paulo General Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-12-10
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.